Ultragenyx Pharmaceutical reported $-122428000 in Net Income for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -43.87M 22.58M
Acceleron Pharma XLRN:US $ -63.52M 0.05M
Agios Pharmaceuticals AGIO:US $ -86.22M 1960.54M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
Alnylam Pharmaceuticals ALNY:US $ -189.56M 10.73M
Aptinyx Inc APTX:US $ -19819000 5.59M
Biocryst Pharmaceuticals BCRX:US $ -43.2M 21.09M
Biomarin Pharmaceutical BMRN:US $ 12.94M 4.43M
Bluebird Bio BLUE:US $ -241.7M 35.89M
Epizyme EPZM:US $ -64.36M 5.91M
Esperion Therapeutics ESPR:US $ -43668000 47.27M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Insmed INSM:US $ -117321000 25.68M
IONIS PHARMACEUT IONS:US $ -80.88M 8.99M
Karyopharm Therapeutics KPTI:US $ -53582000 3.83M
Kyowa Hakko Kirin 4151:JP Y 12151M 770M
Macrogenics MGNX:US $ -39.94M 11.34M
Mirati Therapeutics MRTX:US $ -166.43M 30.75M
Moderna Inc MRNA:US 2.78B 1.56B
Neurocrine Biosciences NBIX:US $ 42.3M 10.2M
Ptc Therapeutics PTCT:US $ -118.37M 10.27M
Puma Biotechnology PBYI:US $ -5.11M 21.63M
Regeneron Pharmaceuticals REGN:US $ 3098.9M 1983.7M
Sarepta Therapeutics SRPT:US $ -81.4M 85.84M
Ultragenyx Pharmaceutical RARE:US $ -122.43M 13.71M
Vertex Pharmaceuticals VRTX:US $ 66.92M 586.21M
Vital Therapies VTL:US $ -17.93M 16.6M
Xoma XOMA:US $ -2237000 5.14M